Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • California guideCalifornia Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›California
  4. ›UCI-RFP-26PTK013 BrainBrew Intranasal Drug and Delivery Device for…

University of California·California

UCI-RFP-26PTK013 BrainBrew Intranasal Drug and Delivery Device for Alzheimer's

Closes 10/16/2026
Get bids like this by emailBid source

Description

Click the "Link to bid" button below for more information

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Key dates

Opened
8/18/2026
Closes
10/16/2026

Last updated

Details

Industry
Healthcare and Medical Services
NAICS
541714

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 70%

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 11/5/2027Opened 11/15/2021

U.S. National Institutes of Health·United States of America

70% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 6/17/2027Opened 8/13/2026

U.S. National Institutes of Health·United States of America

69% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. National Institutes of Health·United States of America

69% match

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Closes 5/7/2028Opened 12/30/2024

U.S. National Institutes of Health·United States of America

69% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

67% match

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closes 8/18/2027Opened 10/1/2024

U.S. National Institutes of Health·United States of America

67% match

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

Closes 10/28/2027Opened 6/9/2025

U.S. Department Of Health And Human Services·District of Columbia

66% match

Brain Repair of Any Injured Neural Structure (BRAINS)

Closes 2/26/2027Opened 6/8/2026

U.S. National Institutes of Health·United States of America

66% match

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)

Closes 1/28/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

66% match

BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research

Closes 6/9/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

66% match

BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)

Closes 10/6/2028Opened 5/9/2025

U.S. National Institutes of Health·United States of America

66% match

HEAL Initiative: Optimization of Therapeutic Medical Devices through Team Science Mechanistic Research (RM1)

Closes 10/29/2026Opened 3/16/2026

U.S. National Institutes of Health·United States of America

66% match

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

66% match

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Closes 11/9/2026Opened 2/12/2026

U.S. National Institutes of Health·United States of America

66% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

66% match

BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)

Closes 6/23/2028Opened 8/28/2025

U.S. National Institutes of Health·United States of America

65% match

Functional Target Validation for Alzheimer's Disease-Related Dementias

Closes 11/5/2026Opened 3/11/2026

U.S. National Institutes of Health·United States of America

65% match

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/8/2023

U.S. National Institutes of Health·United States of America

65% match

Data Coordinating Center for the Aging and Alzheimer?s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 6/20/2025

U.S. National Institutes of Health·United States of America

65% match

Translational Centers Using Microphysiologic Systems for Infectious Diseases

Closes 1/28/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

65% match

Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships

Closes 6/16/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

65% match

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Closes 11/19/2026Opened 8/23/2023

U.S. National Institutes of Health·United States of America

65% match

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2027Opened 6/16/2023

U.S. National Institutes of Health·United States of America

65% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 11/10/2026Opened 8/28/2025

U.S. National Institutes of Health·United States of America

64% match

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development

Closes 6/15/2027Opened 7/7/2026